These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 26905431)
41. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein. Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730 [TBL] [Abstract][Full Text] [Related]
42. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells. Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768 [TBL] [Abstract][Full Text] [Related]
43. Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals. Callahan PM; Bertrand D; Bertrand S; Plagenhoef MR; Terry AV Neuropharmacology; 2017 May; 117():422-433. PubMed ID: 28259598 [TBL] [Abstract][Full Text] [Related]
44. SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda. Tjiu JW; Lin PJ; Wu WH; Cheng YP; Chiu HC; Thong HY; Chiang BL; Yang WS; Jee SH Br J Dermatol; 2011 Jan; 164(1):47-53. PubMed ID: 20854438 [TBL] [Abstract][Full Text] [Related]
45. The influence of allosteric modulators and transmembrane mutations on desensitisation and activation of α7 nicotinic acetylcholine receptors. Chatzidaki A; D'Oyley JM; Gill-Thind JK; Sheppard TD; Millar NS Neuropharmacology; 2015 Oct; 97():75-85. PubMed ID: 25998276 [TBL] [Abstract][Full Text] [Related]
46. Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome. Mulcahy MJ; Blattman SB; Barrantes FJ; Lukas RJ; Hawrot E PLoS One; 2015; 10(8):e0134409. PubMed ID: 26258666 [TBL] [Abstract][Full Text] [Related]
47. ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Mastrangeli R; Donini S; Kelton CA; He C; Bressan A; Milazzo F; Ciolli V; Borrelli F; Martelli F; Biffoni M; Serlupi-Crescenzi O; Serani S; Micangeli E; El Tayar N; Vaccaro R; Renda T; Lisciani R; Rossi M; Papoian R Eur J Dermatol; 2003; 13(6):560-70. PubMed ID: 14721776 [TBL] [Abstract][Full Text] [Related]
48. The human alpha7 nicotinic acetylcholine receptor is a host target for the rabies virus glycoprotein. O'Brien BCV; Thao S; Weber L; Danielson HL; Boldt AD; Hueffer K; Weltzin MM Front Cell Infect Microbiol; 2024; 14():1394713. PubMed ID: 38836054 [TBL] [Abstract][Full Text] [Related]
49. Alexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling alpha 7 nicotinic acetylcholine receptors. Hone AJ; Whiteaker P; Mohn JL; Jacob MH; McIntosh JM J Neurochem; 2010 Aug; 114(4):994-1006. PubMed ID: 20492354 [TBL] [Abstract][Full Text] [Related]
50. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists. Criado M; Mulet J; Sala F; Sala S; Colmena I; Gandía L; Bautista-Aguilera OM; Samadi A; Chioua M; Marco-Contelles J ACS Chem Neurosci; 2016 Aug; 7(8):1157-65. PubMed ID: 27254782 [TBL] [Abstract][Full Text] [Related]
51. Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. Grando SA J Pharmacol Sci; 2008 Feb; 106(2):174-9. PubMed ID: 18285656 [TBL] [Abstract][Full Text] [Related]
53. Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of α7 nicotinic acetylcholine receptors. Bychkov M; Shenkarev Z; Shulepko M; Shlepova O; Kirpichnikov M; Lyukmanova E PLoS One; 2019; 14(5):e0217339. PubMed ID: 31150435 [TBL] [Abstract][Full Text] [Related]
54. Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda. Adeyo O; Oberer M; Ploug M; Fong LG; Young SG; Beigneux AP Br J Dermatol; 2015 Oct; 173(4):1066-9. PubMed ID: 25919322 [No Abstract] [Full Text] [Related]
55. Auto/paracrine nicotinergic peptides participate in cutaneous stress response to wounding. Chernyavsky AI; Marchenko S; Phillips C; Grando SA Dermatoendocrinol; 2012 Jul; 4(3):324-30. PubMed ID: 23467535 [TBL] [Abstract][Full Text] [Related]
56. Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay. Elnagar MR; Walls AB; Helal GK; Hamada FM; Thomsen MS; Jensen AA Eur J Pharmacol; 2018 May; 826():106-113. PubMed ID: 29501870 [TBL] [Abstract][Full Text] [Related]
57. Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum. Guerra-Álvarez M; Moreno-Ortega AJ; Navarro E; Fernández-Morales JC; Egea J; López MG; Cano-Abad MF J Neurochem; 2015 May; 133(3):309-19. PubMed ID: 25650007 [TBL] [Abstract][Full Text] [Related]
58. Amphetamine enantiomers inhibit homomeric α7 nicotinic receptor through a competitive mechanism and within the intoxication levels in humans. Garton DR; Ross SG; Maldonado-Hernández R; Quick M; Lasalde-Dominicci JA; Lizardi-Ortiz JE Neuropharmacology; 2019 Jan; 144():172-183. PubMed ID: 30359640 [TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptors. Hogenkamp DJ; Ford-Hutchinson TA; Li WY; Whittemore ER; Yoshimura RF; Tran MB; Johnstone TB; Bascom GD; Rollins H; Lu L; Gee KW J Med Chem; 2013 Nov; 56(21):8352-65. PubMed ID: 24098954 [TBL] [Abstract][Full Text] [Related]